JP2023540934A5 - - Google Patents

Info

Publication number
JP2023540934A5
JP2023540934A5 JP2023514021A JP2023514021A JP2023540934A5 JP 2023540934 A5 JP2023540934 A5 JP 2023540934A5 JP 2023514021 A JP2023514021 A JP 2023514021A JP 2023514021 A JP2023514021 A JP 2023514021A JP 2023540934 A5 JP2023540934 A5 JP 2023540934A5
Authority
JP
Japan
Application number
JP2023514021A
Other languages
Japanese (ja)
Other versions
JPWO2022047186A5 (https=
JP2023540934A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/047998 external-priority patent/WO2022047186A1/en
Publication of JP2023540934A publication Critical patent/JP2023540934A/ja
Publication of JPWO2022047186A5 publication Critical patent/JPWO2022047186A5/ja
Publication of JP2023540934A5 publication Critical patent/JP2023540934A5/ja
Pending legal-status Critical Current

Links

JP2023514021A 2020-08-28 2021-08-27 Rasタンパク質のターゲットエンゲージメントアッセイ Pending JP2023540934A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063071694P 2020-08-28 2020-08-28
US63/071,694 2020-08-28
US202063117080P 2020-11-23 2020-11-23
US63/117,080 2020-11-23
US202163160120P 2021-03-12 2021-03-12
US63/160,120 2021-03-12
PCT/US2021/047998 WO2022047186A1 (en) 2020-08-28 2021-08-27 Target engagement assay for ras proteins

Publications (3)

Publication Number Publication Date
JP2023540934A JP2023540934A (ja) 2023-09-27
JPWO2022047186A5 JPWO2022047186A5 (https=) 2024-09-03
JP2023540934A5 true JP2023540934A5 (https=) 2024-09-03

Family

ID=77914456

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023514021A Pending JP2023540934A (ja) 2020-08-28 2021-08-27 Rasタンパク質のターゲットエンゲージメントアッセイ

Country Status (5)

Country Link
US (1) US20220064696A1 (https=)
EP (1) EP4204808A1 (https=)
JP (1) JP2023540934A (https=)
CN (1) CN116391129A (https=)
WO (1) WO2022047186A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210006356A (ko) 2018-04-04 2021-01-18 아비나스 오퍼레이션스, 인코포레이티드 단백질분해 조절제 및 연관된 사용 방법
CN121419983A (zh) 2023-01-26 2026-01-27 阿尔维纳斯运营股份有限公司 基于小脑蛋白的kras降解protac及其相关用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4812409A (en) 1986-01-31 1989-03-14 Eastman Kodak Company Hydrolyzable fluorescent substrates and analytical determinations using same
US4810636A (en) 1986-12-09 1989-03-07 Miles Inc. Chromogenic acridinone enzyme substrates
US6162931A (en) 1996-04-12 2000-12-19 Molecular Probes, Inc. Fluorinated xanthene derivatives
US7429472B2 (en) 2003-01-31 2008-09-30 Promega Corporation Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
EP1594962B1 (en) 2003-01-31 2014-08-27 Promega Corporation Covalent tethering of functional groups to proteins
US7425436B2 (en) 2004-07-30 2008-09-16 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
WO2008118445A1 (en) 2007-03-26 2008-10-02 Promega Corporation Methods to quench light from optical reactions
GB0905840D0 (en) 2009-04-06 2009-05-20 Sagentia Ltd Apparatus and methods
ES2795287T3 (es) 2009-05-01 2020-11-23 Promega Corp Luciferasas de Oplophorus sintéticas con mayor emisión de luz
JP5677041B2 (ja) 2009-11-11 2015-02-25 株式会社ニデック 眼科装置
SG10202103336SA (en) 2010-11-02 2021-04-29 Promega Corp Novel coelenterazine substrates and methods of use
GB201103631D0 (en) * 2011-03-03 2011-04-13 Univ Leeds Identification of candidate therapeutics
JP5751030B2 (ja) 2011-06-03 2015-07-22 ソニー株式会社 表示制御装置、表示制御方法、及びプログラム
WO2013078244A1 (en) 2011-11-21 2013-05-30 Promega Corporation Carboxy x rhodamine analogs
US20140099654A1 (en) 2012-09-26 2014-04-10 Promega Corporation Real-time monitoring
KR102292431B1 (ko) 2012-12-12 2021-08-20 프로메가 코포레이션 세포내 생물발광 공명 에너지 전이를 이용하여 생물활성제에 의한 세포 표적 결합의 인식
US10067149B2 (en) * 2012-12-12 2018-09-04 Promega Corporation Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
ES2926463T3 (es) 2013-03-15 2022-10-26 Promega Corp Activación de la bioluminiscencia mediante complementación estructural
JP2018533939A (ja) * 2015-10-19 2018-11-22 アラクセス ファーマ エルエルシー Rasの阻害剤をスクリーニングするための方法
JP7092677B2 (ja) 2016-02-15 2022-06-28 プロメガ コーポレイション セレンテラジン類似体
JP7212612B2 (ja) 2016-07-28 2023-01-25 プロメガ コーポレイション セレンテラジン類縁体
WO2019173683A1 (en) * 2018-03-08 2019-09-12 Stc. Unm Discovery of novel molecules and repurposed drugs for ras family gtpases
WO2019241438A2 (en) 2018-06-12 2019-12-19 Promega Corporation Multipartite luciferase

Similar Documents

Publication Publication Date Title
JP2023540934A5 (https=)
BR102021016551A2 (https=)
CN305530537S (https=)
CN306331947S (https=)
CN306068025S (https=)
CN306066950S (https=)
CN305537331S (https=)
CN305536787S (https=)
CN305536703S (https=)
CN305535420S (https=)
CN306335407S (https=)
CN305535404S (https=)
CN305535195S (https=)
CN305534110S (https=)
CN305534032S (https=)
CN305533833S (https=)
CN306073184S (https=)
CN306073542S (https=)
CN305532896S (https=)
CN306063592S (https=)
CN306059564S (https=)
CN305531903S (https=)
CN305531126S (https=)
CN305531054S (https=)
CN305530269S (https=)